Latest Insider Transactions at Steris PLC (STE)
This section provides a real-time view of insider transactions for Steris PLC (STE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of STERIS plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of STERIS plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2023
|
Mohsen Sohi Director |
SELL
Open market or private sale
|
Direct |
2,069
-8.47%
|
$438,628
$212.28 P/Share
|
|
May 15
2023
|
Mohsen Sohi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,069
+7.81%
|
$88,967
$43.92 P/Share
|
|
Mar 03
2023
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
1,150
-9.2%
|
$218,500
$190.21 P/Share
|
|
Feb 15
2023
|
Richard C Breeden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,657
+9.81%
|
$200,251
$43.92 P/Share
|
|
Dec 02
2022
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
98
-2.03%
|
$18,718
$191.91 P/Share
|
|
Dec 02
2022
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
333
+6.47%
|
-
|
|
Dec 01
2022
|
Cary L Majors SVP and President, Healthcare |
SELL
Open market or private sale
|
Direct |
1,600
-11.35%
|
$307,200
$192.51 P/Share
|
|
Oct 10
2022
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
149
-1.12%
|
$25,032
$168.56 P/Share
|
|
Oct 10
2022
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
503
+3.58%
|
-
|
|
Oct 07
2022
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-2.14%
|
$30,430
$170.19 P/Share
|
|
Oct 07
2022
|
Andrew Xilas SVP and GM, Dental |
BUY
Exercise of conversion of derivative security
|
Direct |
606
+6.61%
|
-
|
|
Oct 03
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
91
-0.33%
|
$15,470
$170.07 P/Share
|
|
Oct 03
2022
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-2.24%
|
$14,450
$170.07 P/Share
|
|
Oct 03
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-2.29%
|
$29,070
$170.07 P/Share
|
|
Oct 03
2022
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
914
-2.26%
|
$155,380
$170.07 P/Share
|
|
Oct 03
2022
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
39
-0.64%
|
$6,630
$170.07 P/Share
|
|
Jun 15
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Open market or private sale
|
Direct |
2,659
-8.69%
|
$545,095
$205.31 P/Share
|
|
Jun 02
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
368
-1.19%
|
$83,536
$227.32 P/Share
|
|
Jun 02
2022
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
88
-1.43%
|
$19,976
$227.32 P/Share
|
|
Jun 02
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.64%
|
$28,375
$227.32 P/Share
|
|
Jun 02
2022
|
Richard C Breeden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,218
+7.77%
|
$102,976
$32.36 P/Share
|
|
Jun 02
2022
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
2,140
+13.18%
|
-
|
|
Jun 02
2022
|
Andrew Xilas SVP and GM, Dental |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+27.1%
|
-
|
|
Jun 02
2022
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,476
+18.96%
|
-
|
|
Jun 02
2022
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
564
+8.43%
|
-
|
|
Jun 02
2022
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
2,256
+5.41%
|
-
|
|
Jun 02
2022
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
900
+12.76%
|
-
|
|
Jun 02
2022
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,028
+21.86%
|
-
|
|
Jun 02
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
3,384
+9.85%
|
-
|
|
Jun 02
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,408
+15.62%
|
-
|
|
Jun 01
2022
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-3.28%
|
$39,338
$221.46 P/Share
|
|
Jun 01
2022
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
235
-4.31%
|
$51,935
$221.46 P/Share
|
|
Jun 01
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
675
-2.39%
|
$149,175
$221.46 P/Share
|
|
Jun 01
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
42
-0.67%
|
$9,282
$221.46 P/Share
|
|
May 31
2022
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
942
-14.78%
|
$214,776
$228.2 P/Share
|
|
May 31
2022
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
810
-2.54%
|
$184,680
$228.2 P/Share
|
|
May 31
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,769
-8.93%
|
$631,332
$228.2 P/Share
|
|
May 31
2022
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
72
-1.14%
|
$16,416
$228.2 P/Share
|
|
May 31
2022
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,285
-3.34%
|
$292,980
$228.2 P/Share
|
|
May 31
2022
|
Cary L Majors SVP and President, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
742
-5.84%
|
$169,176
$228.2 P/Share
|
|
May 31
2022
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
151
-2.64%
|
$34,428
$228.2 P/Share
|
|
Apr 20
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Open market or private sale
|
Direct |
8,000
-20.5%
|
$2,040,000
$255.48 P/Share
|
|
Apr 20
2022
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+17.01%
|
$536,000
$67.98 P/Share
|
|
Apr 07
2022
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Open market or private sale
|
Direct |
8,000
-17.23%
|
$2,000,000
$250.0 P/Share
|
|
Mar 29
2022
|
Karen L Burton VP & CAO |
SELL
Open market or private sale
|
Direct |
4,000
-38.55%
|
$984,000
$246.0 P/Share
|
|
Mar 29
2022
|
Karen L Burton VP & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+27.83%
|
$308,000
$77.07 P/Share
|
|
Feb 15
2022
|
Karen L Burton VP & CAO |
SELL
Open market or private sale
|
Direct |
2,600
-28.97%
|
$603,200
$232.61 P/Share
|
|
Feb 15
2022
|
Karen L Burton VP & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+22.46%
|
$179,400
$69.72 P/Share
|
|
Feb 10
2022
|
Cynthia L Feldmann Director |
SELL
Open market or private sale
|
Direct |
1,891
-72.84%
|
$442,494
$234.1 P/Share
|
|
Feb 10
2022
|
Cynthia L Feldmann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,891
+42.14%
|
$134,261
$71.4 P/Share
|